These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6199986)

  • 1. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients.
    Ninan PT; van Kammen DP; Scheinin M; Linnoila M; Bunney WE; Goodwin FK
    Am J Psychiatry; 1984 Apr; 141(4):566-9. PubMed ID: 6199986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
    Schizophr Res; 2009 Jul; 112(1-3):80-5. PubMed ID: 19410429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal.
    Stanley B; Molcho A; Stanley M; Winchel R; Gameroff MJ; Parsons B; Mann JJ
    Am J Psychiatry; 2000 Apr; 157(4):609-14. PubMed ID: 10739421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Auto)aggression and CSF 5-HIAA in depression and schizophrenia.
    van Praag HM
    Psychopharmacol Bull; 1986; 22(3):669-73. PubMed ID: 2432628
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters.
    Moberg T; Nordström P; Forslund K; Kristiansson M; Asberg M; Jokinen J
    J Affect Disord; 2011 Jul; 132(1-2):173-8. PubMed ID: 21356560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia.
    Cooper SJ; Kelly CB; King DJ
    Lancet; 1992 Oct; 340(8825):940-1. PubMed ID: 1383659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles.
    Potkin SG; Weinberger DR; Linnoila M; Wyatt RJ
    Am J Psychiatry; 1983 Jan; 140(1):21-5. PubMed ID: 6183980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers for suicidal behavior.
    Banki CM
    Am J Psychiatry; 1985 Jan; 142(1):147-8. PubMed ID: 2578258
    [No Abstract]   [Full Text] [Related]  

  • 10. CSF 5-HIAA and suicide in non-depressed schizophrenics.
    van Praag HM
    Lancet; 1983 Oct; 2(8356):977-8. PubMed ID: 6195497
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters.
    Chatzittofis A; Nordström P; Hellström C; Arver S; Åsberg M; Jokinen J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1280-7. PubMed ID: 23453639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF 5-hydroxyindoleacetic acid levels and suicide attempts in schizophrenia.
    Lemus CZ; Lieberman JA; Johns CA; Pollack S; Bookstein P; Cooper TB
    Biol Psychiatry; 1990 Apr; 27(8):926-9. PubMed ID: 1691927
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM; Lindström LH
    Psychiatry Res; 1998 Nov; 81(2):101-10. PubMed ID: 9858027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.
    Malone KM; Waternaux C; Haas GL; Cooper TB; Li S; Mann JJ
    Am J Psychiatry; 2003 Apr; 160(4):773-9. PubMed ID: 12668368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
    Nord J Psychiatry; 2011 Apr; 65(2):101-5. PubMed ID: 20662686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients.
    Edman G; Asberg M; Levander S; Schalling D
    Arch Gen Psychiatry; 1986 Jun; 43(6):586-92. PubMed ID: 2423049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin, suicide and schizophrenia.
    Roy A
    Can J Psychiatry; 1993 Jun; 38(5):369. PubMed ID: 7688651
    [No Abstract]   [Full Text] [Related]  

  • 20. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.